Health Condition 1: F112- Opioid dependence
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meeting ICD-11 diagnostic criteria of opioid dependence 2. Presence of responsible adult family member 3. Patient or/and family member having access to a mobile phone 4. Willing for daily telemedicine follow-up for at least three consecutive days
Exclusion criteria
Exclusion criteria: 1. Uncooperative patients/ Unwilling caregivers. 2. Previously diagnosed with a comorbid serious mental illness 3. Presenting with comorbid severe physical illness (e.g. Liver, renal dysfunction)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment retention at one week. Treatment retention will be defined by the proportion of participants who follows up at the outpatient clinic at 7 ± 3 days of Buprenorphine-naloxone (BPNX)induction.Timepoint: 01 week | — |
Secondary
| Measure | Time frame |
|---|---|
| Abstinence from illegal opioids at follow-ups and total number of days of abstinence from illegal opioids during the follow-up period: abstinence from illicit opioids (i.e., any other non-prescription opioid use except buprenorphine) will be defined by (a) subjective reporting of 7-day abstinence and (b) negative urine screen for morphine and tramadol at the follow-upsTimepoint: 01 week;opioid craving and withdrawal symptoms - opioid cravings and withdrawal will be assessed by structured and standardized instrumentsTimepoint: 01 week;patient-reported outcomes such as quality of life and satisfaction: these constructs will be assessed by structured and standardized instruments.Timepoint: 01 week;Telehealth satisfaction in the TABI group: by appropriate standardized instruments.Timepoint: 01 week | — |
Countries
India
Contacts
Postgraduate Institute of Medical Education and Research Chandigarh, India